A Stable Producer Cell Line for the Manufacture of a Lentiviral Vector for Gene Therapy of Parkinson's Disease

2011 ◽  
Vol 22 (3) ◽  
pp. 357-369 ◽  
Author(s):  
Hannah J. Stewart ◽  
Liang Fong-Wong ◽  
Iain Strickland ◽  
Daniel Chipchase ◽  
Michelle Kelleher ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Gene Therapy ◽  
Parkinson's Disease ◽  
Cell Line ◽  
Lentiviral Vector ◽  
Producer Cell Line ◽  
Producer Cell

scholarly journals 458. Development of a Stable Producer Cell Line for Scalable Lentiviral Vector Production for Gene Therapy of Hemoglobinopathie

2016 ◽  
Vol 24 ◽  
pp. S182
Author(s):  
Sarah Slauson ◽  
Amelia Thomas ◽  
Byoung Ryu ◽  
Melissa Bonner ◽  
Gretchen Lewis ◽  
...  
Keyword(s):  
Gene Therapy ◽  
Cell Line ◽  
Lentiviral Vector ◽  
Producer Cell Line ◽  
Producer Cell

Long-term safety and tolerability of ProSavin, a lentiviral vector-based gene therapy for Parkinson's disease: a dose escalation, open-label, phase 1/2 trial

The Lancet ◽  
2014 ◽  
Vol 383 (9923) ◽  
pp. 1138-1146 ◽  
Author(s):  
Stéphane Palfi ◽  
Jean Marc Gurruchaga ◽  
G Scott Ralph ◽  
Helene Lepetit ◽  
Sonia Lavisse ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Gene Therapy ◽  
Parkinson's Disease ◽  
Dose Escalation ◽  
Lentiviral Vector ◽  
Phase 1 ◽  
Open Label ◽  
Open Label Phase

Delayed gene therapy of glial cell line-derived neurotrophic factor is efficacious in a rat model of Parkinson's disease

2005 ◽  
Vol 134 (1) ◽  
pp. 155-161 ◽  
Author(s):  
Jie-Sheng Zheng ◽  
Ling-Ling Tang ◽  
Shu-Sen Zheng ◽  
Ren-Ya Zhan ◽  
Yong-Qing Zhou ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Gene Therapy ◽  
Parkinson's Disease ◽  
Cell Line ◽  
Glial Cell ◽  
Rat Model ◽  
Neurotrophic Factor

scholarly journals Long-Term Follow-Up of a Phase I/II Study of ProSavin, a Lentiviral Vector Gene Therapy for Parkinson's Disease

2018 ◽  
Vol 29 (3) ◽  
pp. 148-155 ◽  
Author(s):  
Stéphane Palfi ◽  
Jean Marc Gurruchaga ◽  
Hélène Lepetit ◽  
Katy Howard ◽  
G. Scott Ralph ◽  
...  
Keyword(s):  
Parkinson’S Disease ◽  
Gene Therapy ◽  
Parkinson's Disease ◽  
Phase I ◽  
Lentiviral Vector ◽  
Long Term Follow Up
Sign in / Sign up

Export Citation Format

Share Document